Resumen
Introducción: en diciembre de 2019, el coronavirus 2 causante del síndrome respiratorio agudo severo (SARS-CoV-2) provocó un brote en Wuhan, China, de la enfermedad respiratoria denominada COVID-19. A finales de febrero de 2020 se detectó en México el primer caso de COVID-19. Con esta enfermedad, las enfermedades crónicas degenerativas son determinantes para que la comorbilidad continúe en aumento.
Objetivo: conocer las características epidemiológicas y la comorbilidad en trabajadores enfermos de COVID-19 del Órgano de Operación Administrativa Desconcentrada Estatal Veracruz Norte, del Instituto Mexicano del Seguro Social (IMSS).
Material y métodos: estudio descriptivo y transversal que incluyó a 228 pacientes de COVID-19, trabajadores del IMSS. Se analizaron variables como edad, género, así como unidad médica, categoría contractual, comorbilidades, etcétera, las cuales se tomaron de abril a junio de 2020 de la base del Sistema de Notificación en Línea para la Vigilancia Epidemiológica (SINOLAVE). Se empleó estadística descriptiva y chi cuadrada de Pearson, con una p < 0.05.
Resultados: se analizaron 228 pacientes. El personal de enfermería fue el de mayor prevalencia, con 101 pacientes (44.3%). Las comorbilidades más frecuentes fueron la obesidad en primer plano, con 27 pacientes (11.8%), y la diabetes mellitus por sí sola con 15 (6.6%), y en conjunto, con hipertensión arterial, obesidad y ser fumador crónico se presentaron en 22 pacientes (9.6 %).
Conclusiones: predominó el personal de enfermería; las comorbilidades prevalentes fueron la obesidad, la diabetes mellitus y la hipertensión arterial.
Abstract
Background: In December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of the respiratory disease called COVID-19, in Wuhan, China. At the end of February 2020, it was detected in Mexico the first case of COVID-19. With this disease, chronic degenerative diseases are decisive for comorbidity to continue increasing.
Objective: To know the epidemiological characteristics and comorbidity in workers sick with COVID-19 from the Veracruz Norte Regional Deconcentrated Administrative Operation Body, from the Mexican Institute for Social Security (Instituto Mexicano del Seguro Social, IMSS).
Material and methods: Descriptive, cross-sectional study, which included 228 COVID-19 patients, who were IMSS workers. Variables such as age, gender, as well as medical unit, contractual category, comorbidities, etc., were analyzed and were taken from April to June 2020 from the Online Notification System for Epidemiological Surveillance (SINOLAVE) database. It was used descriptive statistics, and Pearson’s chi-squared, with a p < 0.05.
Results: 228 patients were analyzed. The nursing staff was the one with the highest prevalence with 101 patients (44.3%). Comorbidities such as obesity in the foreground, with 27 patients (11.8%), and diabetes mellitus alone with 15 patients (6.6%), and as a group, along with arterial hypertension, obesity and being a chronic smoker in 22 patients (9.6%) were the most frequent.
Conclusions: The nursing staff predominated; the prevalent comorbidities were obesity, diabetes mellitus and arterial hypertension.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382(19):1787-99.
Fauci AS, Lane HC, Redfield RR. Covid-19 — navigating the uncharted. N Engl J Med 2020; 382(13):1268-9. doi: 10.1056/ NEJMe2002387.
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. COVID-19 in critically ill patients in the Seattle Region — case series. N Engl J Med. 2020;382:1268-9 doi: 10.1056/NEJMoa2004500.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C). 2020;2020:2402961.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292(14):1724-37. doi: 10.1001/ jama.292.14.1724.
Pedraza Zárate MA. Obesity in COVID-19. ES J Nutr Health. 2020;1(2);1011. Disponible en https://escientificlibrary.com/ nutritional-health/Article/ESJNH-V1-1011.pdf.
Moran K. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health. 2020;42:e2020007. doi: 10.4178/epih. e2020007.
McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J Med. 2020;382(21):2005-2011. doi: 10.1056/NEJMoa2005412.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7.
Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab. 2020;105(8):dgaa346. doi:10.1210/clinem/dgaa346.
Khalatbari-Soltani S, Cumming RC, Delpierre C, KellyIrving M. Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards J Epidemiol Community Health. 2020;74:620-3.
Chinese Academy of Sciences. Wuhan coronavirus has strong ability to infect humans. Press release. Jan 21, 2020.
Trullàs JC, Vilardell I, Blasco M, Heredia J. COVID-19 en trabajadores sanitarios del Hospital comarcal de Olot (Girona). Rev Clin Esp. 2020;220(8):529-31.
Casas-Rojo JM, Antón-Santos JM, Núñez-Cortés JM, Lumbreras-Bermejo C, Ramos-Rincón JM, Roy Vallejo E. Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMICOVID-19. Rev Clin Esp. 2020; 220(8):480-94. doi: 10.1016/j. rce.2020.07.003.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi: 10.1056/NEJMoa2002032
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052-9, doi: 10.1001/jama.2020.6775.
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ . 2020;369:m1985. doi: 10.1136/bmj.m1985.
Jin L, Zhao Y, Zhou J, Tao M, Yang Y, Wang X, et al. Distribución temporal, geográfica y por población de la nueva enfermedad por coronavirus (COVID-19) desde el 20 de enero hasta el 10 de febrero del 2020, en China. Rev Clin Esp. 2020;220(8):495-500.
Gobierno del Estado de Veracruz. Mapa del coronavirus. Gobierno del Estado de Veracruz; 2020. Disponible en http:// coronavirus.veracruz.gob.mx/mapa/
Secretaría de Salud/Instituto Nacional de Estadística y Geografía/Instituto Nacional de Salud Pública. Encuesta nacional de salud y nutrición (ENSANUT) 2018. México: SS/ INEGI/INSP; 2019.
Horn EM, Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020:1-3.